Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with ...

Restricted access to genome-editing technologies poses serious challenges for countries like India that urgently need such ...

Researchers are investigating the role of non-coding DNA, or junk DNA, in regulating astrocytes, brain cells involved in ...

Abstract: Accurately predicting the secondary structure of Non-coding RNAs is crucial for understanding their biological roles. However, current methods face challenges in accuracy and computational ...

With a new study in the journal Science Bulletin, researchers at Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University have ...

What keeps our cells the right size? Scientists have long puzzled over this fundamental question, since cells that are too large or too small are linked to many diseases. Until now, the genetic basis ...

Abstract: In the rapidly evolving field of consumer healthcare, the exploration of non-coding RNA interactions is crucial for drug development and personalized therapy. However, through traditional ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...

As nucleic acid–based therapeutics evolve and mature, so too must the analytical tools that are designed to characterize them. New microfluidic capillary electrophoresis (CE) methods that are designed ...

Research indicates that, on average, it can take between 15 and 20 sessions for therapy to result in some form of improvement. However, it’s important to remember that therapy isn’t ‘one size fits all ...